4.5 Article

Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition

期刊

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
卷 22, 期 11, 页码 5617-5628

出版社

WILEY
DOI: 10.1111/jcmm.13836

关键词

Crohn's disease; epithelial to mesenchymal transition; fibrosis; miR-200 family

资金

  1. Shire Innovation Fund

向作者/读者索取更多资源

Intestinal mesenchymal cells deposit extracellular matrix in fibrotic Crohn's disease (CD). The contribution of epithelial to mesenchymal transition (EMT) to the mesenchymal cell pool in CD fibrosis remains obscure. The miR-200 family regulates fibrosis-related EMT in organs other than the gut. E-cadherin, cytokeratin-18 and vimentin expression was assessed using immunohistochemistry on paired strictured (SCD) and non-strictured (NSCD) ileal CD resections and correlated with fibrosis grade. MiR-200 expression was measured in paired SCD and NSCD tissue compartments using laser capture microdissection and RT-qPCR. Serum miR-200 expression was also measured in healthy controls and CD patients with stricturing and non-stricturing phenotypes. Extra-epithelial cytokeratin-18 staining and vimentin-positive epithelial staining were significantly greater in SCD samples (P=0.04 and P=0.03, respectively). Cytokeratin-18 staining correlated positively with subserosal fibrosis (P<0.001). Four miR-200 family members were down-regulated in fresh SCD samples (miR-141, P=0.002; miR-200a, P=0.002; miR-200c, P=0.001; miR-429; P=0.004); miR-200 down-regulation in SCD tissue was localised to the epithelium (P=0.001-0.015). The miR-200 target ZEB1 was up-regulated in SCD samples (P=0.035). No difference in serum expression between patient groups was observed. Together, these observations suggest the presence of EMT in CD strictures and implicate the miR-200 family as regulators. Functional studies to prove this relationship are now warranted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据